Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Deloitte
Cantor Fitzgerald
Harvard Business School
US Department of Justice

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 10,376,578

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,376,578
Title:Compositions and methods for treating Crohn\'s disease and related conditions and infections
Abstract: In alternative embodiments, the invention provides a \"triple combination\" therapy for treating, ameliorating and preventing Crohn\'s Disease (or Crohn syndrome, terminal or distal ileitis or regional enteritis) or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne\'s disease, including genetically-predisposed and chronic disorders, where the microbial or bacterial flora of the bowel is at least one causative or symptom-producing factor; and compositions for practicing same. In alternative embodiments, methods and compositions of the invention comprise or comprise use of therapies, medications, formulations and pharmaceuticals comprising active agents that can suppress or eradicate the microbiota super-infection that causes Crohn\'s Disease or paratuberculosis infection in mammals. In alternative embodiments, the methods and uses of the invention for treating, ameliorating and preventing Crohn\'s Disease and complications of Crohn\'s Disease, or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne\'s disease, comprises administration to an individual (human or mammal) in need thereof: (1) an anti-TNF.alpha. composition, or a composition capable of down-modulating TNF.alpha. activity; (2) a Hyperbaric Oxygen Treatment, or HBOT; and (3) an anti-Mycobacterium avium sub species paratuberculosis (MAP) (an anti-MAP) agent, composition or therapy.
Inventor(s): Agrawal; Gaurav (Manly, AU)
Assignee: Agrawal; Guarav (Manly, AU)
Application Number:15/483,702
Patent Claims:see list of patent claims

Details for Patent 10,376,578

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12   Try a Free Trial Agrawal; Guarav (Manly, AU) 2032-06-04 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12   Try a Free Trial Agrawal; Guarav (Manly, AU) 2032-06-04 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Try a Free Trial Agrawal; Guarav (Manly, AU) 2032-06-04 RX Orphan search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Try a Free Trial Agrawal; Guarav (Manly, AU) 2032-06-04 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKinsey
Chubb
UBS
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.